No Data
No Data
MAIA Biotechnology Announces Director Participation in Recent Private Placement Closings
Express News | Maia Biotechnology Announces Director Participation in Recent Private Placement Closings
Noble Financial Maintains MAIA Biotechnology(MAIA.US) With Buy Rating, Maintains Target Price $14
Sector Update: Health Care Stocks Decline Monday Afternoon
MAIA Biotechnology Granted FDA Rare Pediatric Disease Designation for THIO as a Treatment for Pediatric High-Grade Gliomas
Express News | Maia Biotechnology Granted FDA Rare Pediatric Disease Designation for Thio as a Treatment for Pediatric High-Grade Gliomas
No Data